Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detection

References

• Alvarez A., Pauwels-Vergely C., Paraire M., Poupon M. F. Differential effects of fotemustine and BCNU on metastases and local growth in experimental models. Presented at 6 Congresso Mediterraneo di Chemioterpia. Taormina 1988
   Google Scholar
• Bartosek I., Daniel S., Sykora S. Differential pulse polarographic determination of submicrogram quantities of carmustine and related compounds in biological fluids. Journal of Pharmaceutical Sciences 1978; 67: 1160–1163
   PubMed Web of Science ®Google Scholar
• Bartosek I., Russo R. G., Cattaneo M. T. Pharmacokinetics of nitrosoureas: levels of 1,3-bis-(2-chlorethyl)-1-nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after i.v. bolus. Tumori 1984; 70: 491–498
   PubMed Web of Science ®Google Scholar
• Caddy B., Idowu O. R., Stuart J. F. A high pressure liquid chromatographic procedure for monitoring 1-(2-chlorethyl)-3-(4-trans-methylcyclohexyl)-1-nitrosourea levels in body fluids. Therapeutic Drug Monitoring 1982; 4: 389–395
   PubMed Web of Science ®Google Scholar
• Cudennec C. A., Lavielle G., Deloffre P., Bizzari J. P. Pre-clinical antitumor activity of the nitrosourea, Servier 10036. Presented at 15th International Congress of Chemotherapy. Istanbul 1987
   Google Scholar
• Filippeschi S., Colombo T., Bassani D., De Francesco L., Arioli P., D'Incalci M., Bartosek I., Guaitani A. Antitumor activity of the novel nitrosourea S10036 in rodent tumors. Anticancer Research 1988; 8: 1351–1354
   PubMed Web of Science ®Google Scholar
• Foster D. O., Pardee A. B. Transport of amino acid by confluent and nonconfluent 3T3 and polyoma virus-transformed 3T3 cells growing on glass cover slips. Journal of Biological Chemistry 1969; 244: 2675–2681
   PubMed Web of Science ®Google Scholar
• Freed B. R., McQuinn R. L., Tilbury R. S., Digenis G. A. Distribution of 13N in rat tissues following intravenous administration of nitroso-labeled BCNU. Cancer Chemotherapy and Pharmacology 1982; 10: 16–21
   PubMed Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1975
   Google Scholar
• Gordon B. H., Richards R. P., Hiley M. P., Gray A. J., Ings R. M. J., Campbell D. B. A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. procedure for the measurement of fotemustine kinetics. Xenobiotica 1989; 19: 329–339
   PubMed Web of Science ®Google Scholar
• Jacquillat C. I., Khayat D., Banzet P., Weil M., Fumoleaup P., Namer M., Avril M. F., Lauvin R., Kerbrat P., Vilmer C., Bizzari J. P. Multicentric study of the nitrosourea fotemustine (S10036) in advanced malignant melanoma (AMM) including patients with cerebral metastases. Presented at 2nd International Congress on Neo-Adjuvant Chemotherapy. Paris 1988
   Google Scholar
• Khayat D., Bizzari J. P., Frenay M., Nahan H., Weil M., Goupil A., Namer M., Rouesse J., Banzet P., Jacquillat C. Interim report of phase II study of new nitrosourea S10036 in disseminated malignant melanoma. Journal of the National Cancer Institute 1988; 80: 1407–1408
   PubMedGoogle Scholar
• Khayat D., Lokiec F., Bizzari J. P., Weil M., Meeus L., Sellami M., Rouesse J., Banzet P., Jacquillat C. Phase I clinical study of the new amino-acid linked nitrosourea, S10036, administered on a weekly schedule. Cancer Research 1987; 47: 6782–6785
   PubMed Web of Science ®Google Scholar
• Labarre P., Godeneche D., Madelmont J. C., Triana K., Mathe G., Veyre A. Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography. Journal of Chromatography 1987; 419: 381–387
   PubMed Web of Science ®Google Scholar
• Levin V. A., Kabra P. A., Freeman-Dove M. A. Relationship of 1,3-bis(2-chlorethyl)-1-nitrosourea (BCNU) and 1-(2-chlorethyl)-3-cyclohexyl–nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Cancer Chetnotheraphy and Pharmacology 1978; 1: 233–242
   PubMed Web of Science ®Google Scholar
• Montgomery J. A., Mayo J. G. Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma. Journal of Medicinal Chemistry 1974; 17: 477–480
   PubMed Web of Science ®Google Scholar
• Polacek J., Gunnarsson P. O., Brandin S. Determination of tauromustine, a nitrosourea-based antitumor agent, in plasma by high-performance liquid chromatography. Journal of Chromatography 1988; 425: 424–428
   PubMed Web of Science ®Google Scholar
• Reed D. J. Synthesis and characterisation of nitrosoureas. Anticancer and Interferon Agents. Synthesis and Properties, R. M. Offenbrite, G. B. Buther. Marcel Dekker, New York 1984; 177–202
   Google Scholar
• Russo R. G., Bartosek I., Piazza E., Santi A. M., Libretti A., Garattini S. Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer. Cancer Treatment Reports 1981; 65: 555–562
   PubMedGoogle Scholar
• Russo R. G., Cattaneo M. T., Bartosek L. Pharmacokinetics of nitrosoureas: comparison of 1.3-bis(2-chlorethyl)-1-nitrosourea (BCNU) and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats. Tumori 1984; 70: 499–502
   PubMed Web of Science ®Google Scholar
• Sacchi-Landriani G., Guardabasso V., Rocchetti M. NL-FIT: a microcomputer program for non linear fitting. Computer Programs in Biomedicine 1983; 16: 35–42
   PubMedGoogle Scholar
• Smith R. G., Blackstock S. C., Cheung L. K., Loo T. L. Analysis for nitrosourea antitumor agents by gas chromatography-mass spectrometry. Analytical Chemistry 1981; 53: 1205–1208
   PubMed Web of Science ®Google Scholar
• Smith R. G., Cheung L. K. Determination of two nitrosourea antitumor agents by chemical ionization gas chromatography-mass spectrometry. Journal of Chromatography 1982; 229: 464–469
   PubMed Web of Science ®Google Scholar
• Smith R. G., Cheung L. K., Feun L. G., Loo T. L. Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperididyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry. Biomedical Mass Spectrometry 1983; 10: 404–407
   PubMedGoogle Scholar
• Yeager R. L., Oldfield E. H., Chatterji D. C. Quantitation of 1,3-bis(2-chloroethyl)-1-nitrosourea in plasma using high-performance liquid chromagography. Journal of Chromatography 1984; 305: 496–501
   PubMed Web of Science ®Google Scholar